Year Published
- 2008 (0)
- (-) Remove 2009 filter 2009
- 2010 (1) Apply 2010 filter
- 2011 (0)
- 2012 (2) Apply 2012 filter
- 2013 (0)
- (-) Remove 2014 filter 2014
- 2015 (6) Apply 2015 filter
- 2016 (3) Apply 2016 filter
- 2017 (7) Apply 2017 filter
- (-) Remove 2018 filter 2018
- 2019 (0)
- 2020 (0)
- 2021 (0)
Research Topics
Populations
- Countries/Governments (2) Apply Countries/Governments filter
- Rural Populations (0)
- Smallholder Farmers (3) Apply Smallholder Farmers filter
- Women (0)
Types of Research
- Data Analysis (0)
- (-) Remove Literature Review filter Literature Review
- Portfolio Review (0)
- Research Brief (1) Apply Research Brief filter
Geography
- East Africa Region and Selected Countries (3) Apply East Africa Region and Selected Countries filter
- (-) Remove Global filter Global
- South Asia Region and Selected Countries (5) Apply South Asia Region and Selected Countries filter
- (-) Remove Southern Africa Region and Selected Countries filter Southern Africa Region and Selected Countries
- Sub-Saharan Africa (14) Apply Sub-Saharan Africa filter
- West Africa Region and Selected Countries (4) Apply West Africa Region and Selected Countries filter
Dataset
- ASTI (0)
- FAOSTAT (2) Apply FAOSTAT filter
- Farmer First (0)
- LSMS & LSMS-ISA (0)
- Other Datasets (1) Apply Other Datasets filter
Current search
- (-) Remove Southern Africa Region and Selected Countries filter Southern Africa Region and Selected Countries
- (-) Remove 2014 filter 2014
- (-) Remove 2018 filter 2018
- (-) Remove Global filter Global
- (-) Remove Literature Review filter Literature Review
- (-) Remove 2009 filter 2009
The private sector is the primary investor in health research and development (R&D) worldwide, with investment annual investment exceeding $150 billion, although only an estimated $5.9 billion is focused on diseases that primarily affect low and middle-income countries (LMICs) (West et al., 2017b). Pharmaceutical companies are the largest source of private spending on global health R&D focused on LMICs, providing $5.6 billion of the $5.9 billion in total private global health R&D per year. This report draws on 10-K forms filed by Pharmaceutical companies with the U.S. Securities and Exchange Commission (SEC) in the year 2016 to examine the evidence for five specific disincentives to private sector investment in drugs, vaccines and therapeutics for global health R&D: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed costs for research and manufacturing, and imperfect markets. 10-K reports follow a standard format, including a business section and a risk section which include information on financial performance, investment options, lines of research, promising acquisitions and risk factors (scientific, market, and regulatory). As a result, these filings provide a valuable source of information for analyzing how private companies discuss risks and challenges as well as opportunities associated with global health R&D targeting LMICs.
This report summarizes current trends in the application of Development Finance Institution (DFI)-based returnable capital finance in developing countries, with an emphasis on “pro-poor” development initiatives. We begin by reviewing the financial instruments used by DFIs. We then review the major DFI providers of returnable-capital based finance, drawing on past and present peer-reviewed articles and published reports exploring trends in the uses of different returnable capital instruments over time. Finally, we conclude by further examining recent efforts to use returnable capital to finance development initiatives explicitly targeting the poor.
In Mozambique, the legacies of colonial rule, socialism and civil war continue to constrain economic growth and agricultural production. Eighty percent of Mozambique’s labor force derives its livelihood from agriculture, but the nation remains a net food importer. The majority of all farmland is cultivated by smallholders whose fertilizer usage and crop yields are among the lowest in Africa. While Mozambique has experienced reasonable economic growth since the end of its civil war in 1992, it remains poor by almost any measure. In this literature review, we examine the state of agriculture in Mozambique, the country’s political history and post-war recovery, and the current fertilizer market. We find evidence that smallholder access to fertilizer in Mozambique is limited by lack of information, affordability, access to credit, a poor business environment, and limited infrastructure. The data demonstrate that increased investment in infrastructure is an important step to improve input and output market access for smallholders. The main government intervention currently impacting smallholder fertilizer use is the Agricultural Sector Public Expenditure Program (PROAGRI) initiative, however, more data is necessary to assess the impact of its policies and programs.
This literature review provides information on the dynamics of the maize market and maize prices in Zambia. We address four key topics: average production costs and breakeven prices for maize farmers in Zambia, main drivers of volatility of maize production volumes, key factors driving the differences between Zambian and global maize prices, and policies that may have contributed to increased farmer productivity.
Farmers in Sub-Saharan Africa (SSA) use less fertilizer than farmers in any other region in the world. Low fertilizer use is one factor explaining the lag in agricultural productivity growth in Africa. A variety of market interventions to increase fertilizer use have been attempted over the years, with limited success. In the past several decades, Malawi has tried to alter that trend through a variety of innovative programs aimed at achieving national food security through targeted input subsidy programs. The best known of these programs is Malawi’s Starter Pack Programme. The Starter Pack Programme was amended twice into the Targeted Inputs Programme (TIP) and Expanded Targeted Inputs Programme (ETIP), and eventually replaced with the Agricultural Input Subsidy Programme (AISP). The efficiency and equity of the Starter Pack Programme and its successors have been the subject of debate. This report reviews the history, implementation, and perceived effectiveness of the various input subsidy schemes in the context of Malawi’s political economy. We find that AISP is credited with significantly increasing maize yields in Malawi. However, we also find that there are serious challenges facing the most recent input subsidy program, ranging from the rising cost of the subsidy to ongoing implementation struggles related to increased bureaucracy and corruption.